| FibroGen Reports Proof-of-Principle for Oral Anemia Therapy FG-4592 in ... - PipelineReview.com (press release) |
|
|
PipelineReview.com (press release) “These results represent the first proof-of-principle that FG-4592 can maintain or increase hemoglobin levels in patients with ESRD on hemodialysis using doses that have been shown to be effective in studies of nondialysis patients with chronic kidney ... FibroGen announces proof-of-principle for FG-4592 Phase 2 study in |